Trials / Recruiting
RecruitingNCT03720860
Inflammatory Mediators of Acute Kidney Injury in Intensive Care
Prospective Studie of Inflammatory Markers in Urine, Plasma and Sputum Associated With Acute Kidney Injury
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Uppsala University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Acute kidney injury (AKI) affects more than 50% of patients admitted to the intensive care unit. The most common underlying cause is sepsis. Severe AKI in combination with sepsis is associated with high mortality. The mechanisms for sepsis-induced AKI are largely unknown. Our hypothesis is that the inflammatory response to an infection cause collateral damage to host tissue and contributes to the development of AKI. In this study we want to investigate the presence of novel inflammatory mediators in patients with sepsis, patients subjected to major surgery (sterile inflammation) and non-inflamed patients and correlate their levels with the risk for AKI.
Conditions
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2026-05-01
- Completion
- 2026-05-01
- First posted
- 2018-10-25
- Last updated
- 2026-01-12
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT03720860. Inclusion in this directory is not an endorsement.